ZNF235
gene geneOn this page
Also known as HZF6ANF270
Summary
ZNF235 (zinc finger protein 235, HGNC:12866) is a protein-coding gene on chromosome 19q13.31, encoding Zinc finger protein 235 (Q14590). May be involved in transcriptional regulation.
This gene product belongs to the zinc finger protein superfamily, members of which are regulatory proteins characterized by nucleic acid-binding zinc finger domains. The encoded protein is a member of the Kruppel family of zinc finger proteins, and contains Kruppel-associated box (KRAB) A and B domains and 15 tandemly arrayed C2H2-type zinc fingers. It is an ortholog of the mouse Zfp93 protein. This gene is located in a cluster of zinc finger genes on 19q13.2.
Source: NCBI Gene 9310 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 88 total
- MANE Select transcript:
NM_004234
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12866 |
| Approved symbol | ZNF235 |
| Name | zinc finger protein 235 |
| Location | 19q13.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HZF6, ANF270 |
| Ensembl gene | ENSG00000159917 |
| Ensembl biotype | protein_coding |
| OMIM | 604749 |
| Entrez | 9310 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 6 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay
ENST00000291182, ENST00000587921, ENST00000589248, ENST00000589799, ENST00000591609, ENST00000592844, ENST00000650576, ENST00000947914
RefSeq mRNA: 2 — MANE Select: NM_004234
NM_001411071, NM_004234
CCDS: CCDS33048, CCDS92638
Canonical transcript exons
ENST00000291182 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001048396 | 44298808 | 44298903 |
| ENSE00001300882 | 44304971 | 44305025 |
| ENSE00001314795 | 44286348 | 44289196 |
| ENSE00002440035 | 44299606 | 44299732 |
| ENSE00003621033 | 44303390 | 44303452 |
Expression profiles
Bgee: expression breadth ubiquitous, 177 present calls, max score 86.42.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.7080 / max 71.7681, expressed in 1122 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 181388 | 2.7080 | 1122 |
Top tissues by expression
275 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.42 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.61 | gold quality |
| secondary oocyte | CL:0000655 | 81.74 | gold quality |
| colonic epithelium | UBERON:0000397 | 79.22 | gold quality |
| cortical plate | UBERON:0005343 | 77.02 | gold quality |
| stromal cell of endometrium | CL:0002255 | 76.38 | gold quality |
| ganglionic eminence | UBERON:0004023 | 76.37 | gold quality |
| calcaneal tendon | UBERON:0003701 | 76.11 | gold quality |
| ventricular zone | UBERON:0003053 | 75.82 | gold quality |
| adrenal tissue | UBERON:0018303 | 75.82 | gold quality |
| sural nerve | UBERON:0015488 | 74.78 | gold quality |
| apex of heart | UBERON:0002098 | 74.48 | gold quality |
| granulocyte | CL:0000094 | 74.16 | gold quality |
| tendon | UBERON:0000043 | 73.74 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 72.77 | gold quality |
| right coronary artery | UBERON:0001625 | 72.24 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 72.21 | gold quality |
| cerebellar cortex | UBERON:0002129 | 72.17 | gold quality |
| islet of Langerhans | UBERON:0000006 | 71.48 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 71.47 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 71.38 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 71.38 | gold quality |
| popliteal artery | UBERON:0002250 | 71.34 | gold quality |
| tibial artery | UBERON:0007610 | 71.34 | gold quality |
| lower esophagus | UBERON:0013473 | 71.34 | gold quality |
| leukocyte | CL:0000738 | 71.32 | gold quality |
| cerebellum | UBERON:0002037 | 71.20 | gold quality |
| monocyte | CL:0000576 | 70.93 | gold quality |
| hair follicle | UBERON:0002073 | 70.92 | gold quality |
| oocyte | CL:0000023 | 70.89 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.98 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631), ZNF3 (ENSG00000166526)
Protein
Protein identifiers
Zinc finger protein 235 — Q14590 (reviewed: Q14590)
Alternative names: Zinc finger protein 270, Zinc finger protein 93 homolog, Zinc finger protein HZF6
All UniProt accessions (5): Q14590, K7EKI9, K7EL19, K7ES94, K7ESF8
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q14590-1 | 1 | yes |
| Q14590-2 | 2 |
RefSeq proteins (2): NP_001398000, NP_004225* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050589 | Ikaros_C2H2-ZF | Family |
Pfam: PF00096, PF01352
UniProt features (22 total): zinc finger region 16, sequence conflict 2, chain 1, domain 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q14590-F1 | 67.88 | 0.22 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 72 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_DN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2, STAT1_01, STAT5A_01, BOCHKIS_FOXA2_TARGETS, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP, MIKKELSEN_ES_ICP_WITH_H3K4ME3, MIKKELSEN_NPC_ICP_WITH_H3K4ME3, VERHAAK_GLIOBLASTOMA_CLASSICAL, CHYLA_CBFA2T3_TARGETS_UP, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
GO Biological Process (2): negative regulation of DNA-templated transcription (GO:0045892), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), sequence-specific DNA binding (GO:0043565), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA-templated transcription | 2 |
| regulation of DNA-templated transcription | 2 |
| negative regulation of RNA biosynthetic process | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| DNA binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
572 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF235 | XRCC1 | P18887 | 579 |
| ZNF235 | ZFAND5 | O76080 | 547 |
| ZNF235 | MAPRE2 | Q15555 | 467 |
| ZNF235 | ZBED5 | Q49AG3 | 418 |
| ZNF235 | ZNF608 | Q9ULD9 | 370 |
| ZNF235 | RASGEF1C | Q8N431 | 366 |
| ZNF235 | CCDC12 | Q8WUD4 | 350 |
| ZNF235 | ZMYM5 | Q9UJ78 | 349 |
| ZNF235 | ZNF236 | Q9UL36 | 335 |
| ZNF235 | RHBDD1 | Q8TEB9 | 293 |
| ZNF235 | RSRC1 | Q96IZ7 | 280 |
| ZNF235 | COL26A1 | Q96A83 | 269 |
| ZNF235 | RFX2 | P48378 | 261 |
| ZNF235 | ZBTB20 | Q9HC78 | 241 |
| ZNF235 | ZBTB1 | Q9Y2K1 | 222 |
IntAct
14 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIM28 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| SERTAD4 | POTEF | psi-mi:“MI:0914”(association) | 0.530 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF235 | CDC37 | psi-mi:“MI:0915”(physical association) | 0.370 |
| FAM118B | ZNF235 | psi-mi:“MI:0915”(physical association) | 0.370 |
| MRPL44 | ZNF235 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF235 | PFDN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| FBLN5 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| NOTCH2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| FBLN2 | ZNF316 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF112 | TRIM28 | psi-mi:“MI:0914”(association) | 0.350 |
| uup | ZNF235 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (16): ZNF235 (Affinity Capture-MS), ZNF235 (Affinity Capture-MS), ZNF235 (Affinity Capture-MS), ZNF235 (Affinity Capture-MS), ZNF235 (Affinity Capture-MS), ZNF235 (Affinity Capture-MS), ZNF235 (Affinity Capture-MS), ZNF235 (Affinity Capture-MS), ZNF235 (Affinity Capture-MS), ZNF235 (Affinity Capture-MS), ZNF235 (Affinity Capture-RNA), ZNF235 (Two-hybrid), ZNF235 (Two-hybrid), ZNF235 (Two-hybrid), ZNF235 (Two-hybrid)
ESM2 similar proteins: A0A087WUV0, A0JNB1, A2VDP4, B2RUI1, P0CG31, P10072, P17025, P17036, P17097, P18733, P51814, Q08ER8, Q09FC8, Q0VGE8, Q14590, Q15937, Q16600, Q2M3X9, Q4V8A8, Q5CZA5, Q5R8G9, Q5RBX0, Q5VIY5, Q68DI1, Q6J6I6, Q6NX49, Q6P1L6, Q6PG37, Q6ZMS4, Q6ZMW2, Q80YP6, Q86UD4, Q86Y25, Q8IZ26, Q8N184, Q8NB42, Q8NEK5, Q8TAF7, Q8TF47, Q8WXB4
Diamond homologs: A0A1W2PQL4, A0JNB1, A0JPL0, A6NK53, A6QLU5, A6QPT6, A7MBI1, A8MT65, A8MUV8, A8MWA4, B2RXC5, B4DU55, B4DX44, E9PYI1, O14628, O75346, P0CH99, P0CI00, P17014, P17030, P17032, P17098, P51786, P85977, Q02386, Q06730, Q06732, Q0VAW7, Q12901, Q13360, Q14586, Q14588, Q14590, Q16587, Q2M3X9, Q2VY69, Q32M78, Q3ZCX4, Q49AA0, Q4R6J4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
88 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 78 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1610 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:44260029:G:GT | donor_gain | 1.0000 |
| 19:44264312:A:AG | acceptor_gain | 1.0000 |
| 19:44264313:G:GG | acceptor_gain | 1.0000 |
| 19:44264313:GT:G | acceptor_gain | 1.0000 |
| 19:44264313:GTT:G | acceptor_gain | 1.0000 |
| 19:44264313:GTTC:G | acceptor_gain | 1.0000 |
| 19:44264313:GTTCT:G | acceptor_gain | 1.0000 |
| 19:44264375:GGT:G | donor_loss | 1.0000 |
| 19:44264376:G:GG | donor_gain | 1.0000 |
| 19:44266320:AGTGG:A | donor_loss | 1.0000 |
| 19:44266321:GTGG:G | donor_gain | 1.0000 |
| 19:44266323:GG:G | donor_gain | 1.0000 |
| 19:44266324:GG:G | donor_gain | 1.0000 |
| 19:44266324:GGTGA:G | donor_loss | 1.0000 |
| 19:44266325:G:GG | donor_gain | 1.0000 |
| 19:44266325:G:T | donor_loss | 1.0000 |
| 19:44266862:ACAG:A | acceptor_gain | 1.0000 |
| 19:44266863:C:G | acceptor_gain | 1.0000 |
| 19:44266864:A:AG | acceptor_gain | 1.0000 |
| 19:44266864:A:T | acceptor_loss | 1.0000 |
| 19:44266864:AG:A | acceptor_gain | 1.0000 |
| 19:44266865:G:GT | acceptor_gain | 1.0000 |
| 19:44266865:GG:G | acceptor_gain | 1.0000 |
| 19:44266865:GGC:G | acceptor_gain | 1.0000 |
| 19:44266865:GGCT:G | acceptor_gain | 1.0000 |
| 19:44266865:GGCTA:G | acceptor_gain | 1.0000 |
| 19:44266958:TCAG:T | donor_loss | 1.0000 |
| 19:44266959:CAG:C | donor_loss | 1.0000 |
| 19:44266960:AGG:A | donor_loss | 1.0000 |
| 19:44266961:GG:G | donor_loss | 1.0000 |
AlphaMissense
4983 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:44288199:G:C | F412L | 1.000 |
| 19:44288199:G:T | F412L | 1.000 |
| 19:44288201:A:G | F412L | 1.000 |
| 19:44288283:G:C | F384L | 1.000 |
| 19:44288283:G:T | F384L | 1.000 |
| 19:44288285:A:G | F384L | 1.000 |
| 19:44287443:G:C | F664L | 0.999 |
| 19:44287443:G:T | F664L | 0.999 |
| 19:44287445:A:G | F664L | 0.999 |
| 19:44287510:A:G | L642P | 0.999 |
| 19:44287527:G:C | F636L | 0.999 |
| 19:44287527:G:T | F636L | 0.999 |
| 19:44287529:A:G | F636L | 0.999 |
| 19:44287594:A:G | L614P | 0.999 |
| 19:44287611:G:C | F608L | 0.999 |
| 19:44287611:G:T | F608L | 0.999 |
| 19:44287613:A:G | F608L | 0.999 |
| 19:44287863:G:C | F524L | 0.999 |
| 19:44287863:G:T | F524L | 0.999 |
| 19:44287865:A:G | F524L | 0.999 |
| 19:44287947:A:C | F496L | 0.999 |
| 19:44287947:A:T | F496L | 0.999 |
| 19:44287949:A:G | F496L | 0.999 |
| 19:44288098:A:G | L446P | 0.999 |
| 19:44288115:A:C | F440L | 0.999 |
| 19:44288115:A:T | F440L | 0.999 |
| 19:44288117:A:G | F440L | 0.999 |
| 19:44288182:A:G | L418P | 0.999 |
| 19:44288200:A:G | F412S | 0.999 |
| 19:44288266:A:G | L390P | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000048032 (19:44304979 G>A,C,T), RS1000086480 (19:44289144 G>A), RS1000304467 (19:44291833 A>G), RS1000357073 (19:44292225 G>C), RS1000551161 (19:44298667 A>G), RS1000703215 (19:44298674 G>A), RS1001063259 (19:44303734 G>A), RS1001094937 (19:44302916 A>G), RS1001170783 (19:44298718 G>A), RS1001311658 (19:44304403 C>T), RS1001433486 (19:44303495 T>C), RS1001593520 (19:44292825 C>T), RS1001645830 (19:44306106 T>G), RS1001719462 (19:44306384 G>A), RS1001983353 (19:44285860 G>T)
Disease associations
OMIM: gene MIM:604749 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, affects cotreatment, increases expression | 4 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | increases expression | 1 |
| beta-lapachone | increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Benzene | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Tetradecanoylphorbol Acetate | affects cotreatment, affects expression | 1 |
| Urethane | increases expression | 1 |
| Zinc | affects cotreatment, affects expression | 1 |
| Copper Sulfate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.